Solutions Products Services Customers Partners News About
Overview
Press Releases
Press Archive
Recent Coverage
Events
Press Room Registration
Remote Service Blog
Newsletters
Back to Press Archive

Chiron signs license agreement with Axeda for Device Relationship Management of Blood Screening Devices

MANSFIELD, MA -- January 7, 2003 - Axeda Systems Inc. (NASDAQ: XEDA), the world's leading provider of device relationship management (DRM) enterprise software and services, announced today that Chiron Corporation, a global pharmaceutical company and market leader in blood screening for hepatitis C and HIV-1, has licensed the Axeda DRM™ system to enable the proactive monitoring, service and support of its Procleix® System. In worldwide use today at major blood centers like the American Red Cross, Chiron's Procleix System currently tests more than 70% of the U.S. blood supply. Chiron service professionals will use the Axeda DRM system to remotely monitor Procleix Instrumentation installed at customer facilities, improving service response times and instrument uptimes of these critical medical instruments.

"At Axeda we share Chiron's commitment to quality, innovation and excellence, and we are focused on helping the world's device manufacturers employ DRM technology to become truly proactive enterprises," said Robert M. Russell Jr., CEO of Axeda Systems Inc. "We are extremely pleased that Chiron, a scientific innovator and the global leader in their field, has joined the growing list of leading providers of medical and scientific instruments that have chosen Axeda."

Nucleic acid testing (NAT) is a new, highly sensitive testing approach for improving the safety of the world's blood supply. Moving quickly from concept to commercialization, Chiron and its collaborator, Gen-Probe Incorporated, developed the ProcleixÒ System, a NAT assay and instrument system, in just three years. The Procleix System has proven to significantly reduce the risk of contracting hepatitis C and HIV from blood transfusions. Every year approximately 35 million blood donations are tested in North America, the European Union, and Asia-Pacific. As NAT is adopted in major markets throughout the world, the Procleix System is rapidly gaining acceptance as a leading product for the blood screening market.

The Axeda DRM system is a distributed enterprise software solution that lets service organizations proactively monitor, diagnose, repair and re-supply intelligent devices when remotely deployed at customer sites. Unlike telephone-based systems, Axeda DRM leverages patent-pending Firewall-Friendly™ Internet communications technology to securely transmit instrument data from remote instruments to service representatives, alerting them if an instrument is operating outside preset performance standards. Axeda DRM helps minimize support calls and time on the phone, reduces the number of costly, unscheduled or unnecessary service visits, and increases device uptime to further enhance customer productivity and satisfaction. DRM also enables new, high-value managed-service offerings such as automated consumable replenishment, system upgrades and pay-for-use billing approaches such as cost-per-reportable programs. Ultimately, Axeda DRM enables full-lifecycle feedback that can be used to benefit multiple parts of the business including product development, marketing, sales, operations, and manufacturing.

More information on Axeda and Axeda Software Management is available today from Axeda Systems Inc. and its authorized distributors. Contact Axeda at www.axeda.com or call +1-508-337-9200 for more information.

About Chiron Corporation
Chiron Corporation, headquartered in Emeryville, California, is a global pharmaceutical company that leverages a diverse business model to develop and commercialize high-value products that make a difference in people's lives. The company has a strategic focus on cancer and infectious disease. Chiron applies its advanced understanding of the biology of cancer and infectious disease to develop products from its platforms in proteins, small molecules and vaccines. The company commercializes its products through three business units: biopharmaceuticals, vaccines and blood testing. For more information about Chiron, visit the company's website at www.chiron.com . For more information about Chiron Blood Testing, visit .

About Axeda
Axeda Systems™ Inc. (NASDAQ: XEDA) is the world's leading provider of device relationship management (DRM) enterprise software and services. Axeda helps businesses become more competitive by using the Internet to extract real-time information hidden in their intelligent devices. The company's flagship product, the Axeda Device Relationship Management System™, is a distributed software solution that lets businesses remotely monitor, manage and service intelligent devices, deployed around the world, allowing them to optimize their service, development, sales and manufacturing operations. Axeda customers are Global 2000 companies in many markets including Medical Instrument, Enterprise Technology, Printer and Copier, Industrial and Building Automation, and Semiconductor Equipment industries. Axeda has sales and service offices in the US, Europe and Japan, and distribution partners worldwide. More information about Axeda is available at www.axeda.com .

About Device Relationship Management
Everyday intelligent devices such as copiers, elevators, vending machines, building control units, medical devices, computers and storage systems, and industrial machines are an important new source of business information. Device relationship management systems allow companies to tap into this valuable information anytime anywhere. Pioneered by Axeda, device relationship management technology provides a distributed information management system that leverages the Internet to allow timely, accurate, and unbiased information to be communicated automatically between intelligent devices, wherever they are deployed around the world, and service personnel or enterprise business systems. Device relationship management helps turn reactive businesses into proactive businesses providing new sources of revenue, increased operational efficiency and lower costs, with an ROI that is often measured in months.


Press Contact:
Erin Nolan Smith
Corporate
+1 508-718-6351
enolan@axeda.com

 
 

Customer Videos
Whitepapers, Data Sheets, and Case Studies
Recorded Web Seminars Recorded Web Seminars

Customer Success


Related Links

Upcoming Events  

Your Goals

Solutions for your department